AR and prostate carcinoma: Moreover, we evaluated AR CN status at baseline and progression time points, but AR CN at first radiological evaluation after 3 months of therapy is needed, as it represents the most clinically significant time point, according to Prostate Cancer Clinical Trials Working Group 3 guidelines.